FIXED‐DURATION IBRUTINIB + VENETOCLAX IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): 4‐Y FOLLOW‐UP FROM THE FD COHORT OF THE PHASE 2 CAPTIVATE STUDY

Saved in:
Bibliographic Details
Published inHematological oncology Vol. 41; no. S2; pp. 238 - 239
Main Authors Ghia, P., Allan, J. N., Siddiqi, T., Wierda, W. G., Tam, C. S., Moreno, C., Tedeschi, A., Szafer‐Glusman, E., Zhou, C., Abbazio, C., Dean, J. P., Szoke, A., Barr, P. M.
Format Journal Article
LanguageEnglish
Published Chichester Wiley Subscription Services, Inc 01.06.2023
Subjects
Chronic lymphocytic leukemia
Leukemia
Lymphoma
Online AccessGet full text

Cover

More Information
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.3163_155